Formulation and Evaluation of Herbal Papaya Leaf Syrup

Carica papaya L. leaf has attracted considerable pharmaceutical interest because of its traditional use in febrile illnesses and its possible supportive role in thrombocytopenia. Converting the intensely bitter and chemically complex leaf extract into a syrup may improve taste, dose flexibility, ease of swallowing, and patient acceptability. This narrative review examines published evidence concerning papaya leaf phytochemistry, extraction, syrup formulation, pharmaceutical evaluation, stability, biological activity, and safety. Literature was identified from PubMed, Google Scholar, journal databases, World Health Organization documents, and ICH guidance, with emphasis on peer-reviewed studies and official standards. Published formulations commonly use an aqueous or hydroalcoholic extract with sucrose or honey, purified water, a flavouring agent, and an antimicrobial preservative. The principal quality attributes are appearance, taste, pH, viscosity, specific gravity, extract or marker content, microbial quality, preservative effectiveness, and stability. Formulation reports have produced green to greenish-brown syrups with mildly acidic to near-neutral pH, although compositions and analytical methods vary substantially. Clinical studies suggest that standardized papaya leaf preparations may accelerate platelet recovery in some patients with dengue-associated thrombocytopenia, but systematic reviews judge the overall evidence to be low or uncertain because of heterogeneous products, small samples, inconsistent blinding, and limited reporting of clinically meaningful outcomes. Short-term use is generally well tolerated; nausea, vomiting, altered taste, and occasional rash have been reported, while pregnancy, liver impairment, prolonged use, and possible herb–drug interactions require caution. A scientifically credible papaya leaf syrup therefore requires authenticated raw material, a standardized extract, justified excipient concentrations, validated marker-based assays, microbial control, and real-time stability data. The syrup should be described only as a potential adjunct and must not replace diagnosis, fluid management, monitoring, or other standard medical care in dengue